Zhejiang Anglikang Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio
Zhejiang Anglikang Pharmaceutical Co Ltd Class A capital reinvestment ratio. Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥112.57 Million) in capital expenditures (CN¥16.66 Million). Check 002940 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Capital reinvestment ratio of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart tracks Zhejiang Anglikang Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods. Also explore net asset growth rate of Zhejiang Anglikang Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio by Year (2014–2025)
Zhejiang Anglikang Pharmaceutical Co Ltd Class A capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Zhejiang Anglikang Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥244.13 Million | CN¥49.94 Million | ▼ -45.1% |
| 2024 | 0.37x | CN¥253.60 Million | CN¥94.46 Million | ▼ -17.5% |
| 2023 | 0.45x | CN¥276.91 Million | CN¥124.95 Million | ▲ +21.1% |
| 2022 | 0.37x | CN¥184.75 Million | CN¥68.82 Million | ▼ -15.7% |
| 2021 | 0.44x | CN¥197.65 Million | CN¥87.32 Million | ▼ -3.5% |
| 2020 | 0.46x | CN¥198.61 Million | CN¥90.96 Million | ▲ +29.4% |
| 2019 | 0.35x | CN¥213.49 Million | CN¥75.58 Million | ▼ -30.6% |
| 2018 | 0.51x | CN¥133.61 Million | CN¥68.17 Million | ▲ +80.5% |
| 2017 | 0.28x | CN¥193.77 Million | CN¥54.79 Million | ▲ +55.3% |
| 2016 | 0.18x | CN¥141.74 Million | CN¥25.81 Million | ▼ -28.1% |
| 2015 | 0.25x | CN¥138.59 Million | CN¥35.10 Million | ▼ -73.6% |
| 2014 | 0.96x | CN¥50.46 Million | CN¥48.48 Million | — |